Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

TSX:SVA - Post Discussion

Sernova Corp > I share Redbaron's thoughts
View:
Post by steadfast on Jan 14, 2022 1:59pm

I share Redbaron's thoughts

There has indeed been some nefarious behaviour this week.
However, the decline started last Friday when Dr Loe recommended SVA with
a 29 cent potential profit above the Bid-Ask of $2.21 pre-open.  I respect Dr Loe has a PhD
but he is greatly lacking in common sense with his timing.  Who was going to invest
in a Speculative Stock with a potential return of 13% according to his Jan 7th $2.50 target?

If Dr Phil does indeed have a significant announcement coming, he must ensure
he does not leak ONE WORD to Dr. Loe.  We do not want to read one more
report from him.  We cannot allow him to destroy SVA share price 3x's.
I have emailed my feelings to Dr Phil and given him permission to forward my comments to
Dr Loe. 
SVA needs  a new analyst, one that gives a realistic target.
Comment by Redbaron2211 on Jan 14, 2022 2:04pm
Steadfast agree. At least its better then the -15% potential return he gave with last year's target.    Doe Loe is corrupt or clueless and needs to go.   Hopefully with a TSX listing we can attract some real analysts.  
Comment by MustangSalley on Jan 14, 2022 2:15pm
  Red, I agree with you totally . They need another analyst besides Loe . Graduating to Tsx won't make a difference imo.  IR/PR is incompetent . Time to to fire Matthews . Timing of Shapiro's media blitz is suspicious . Timing of 1 million shares dumped at market open is suspicious .   Long term shareholders are getting frustrated and losing patience .  At ...more  
Comment by BioTeck on Jan 14, 2022 2:23pm
As much of a crook Douggy may be, his target price is realistic based on the news that has been released. The only thing that he missed IMO is the value increase for another patient off insulin. Phil talks a lot of talk but none of it is on paper, only through wally and the red baronator. No credible analyst will price in the value of a rumored "mega deal". No news has been released ...more  
Comment by Redbaron2211 on Jan 14, 2022 3:29pm
That was a big miss Bio.  Putting out a PT the day before data with 13% upside and then another one on the day the data is released at the same PT shows he is attributing 0 value to the new data and loses all creditability in my eyes.    Agree Steadfast, I'm feeling more and more like the data isn't the catalyst in focus.  Last year they did a better job in getting ...more  
Comment by steadfast on Jan 14, 2022 3:41pm
Last year Domenic did a good job in getting the news out. Have been thinking of him this past week and missing his contribution.
Comment by Redbaron2211 on Jan 14, 2022 4:00pm
Very true steadfast.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities